CD4 and tuberculosis: Three sub-group analyses were pre-specified [5], CD4 count strata (<50 and ≥50), level of TB diagnostic certainty (probable or confirmed) and body mass index (BMI) (≤18.5 and >18.5), to assess for heterogeneous treatment effects.